The risk for anemia with targeted therapies for solid tumors

The risk for anemia with targeted therapies for solid tumors

Item
http://www.wikidata.org/entity/Q35989994
Diagnosis and treatment of cancer-related anemia.Infection risk in breast cancer patients treated with trastuzumab: a systematic review and meta-analysis.Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer.Position paper on management of iron deficiency in adult cancer patients.Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer.The impact of anemia on microsurgical breast reconstruction complications and outcomes.Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.Safety profile of combined therapy inhibiting EFGR and VEGF pathways in patients with advanced non-small-cell lung cancer: A meta-analysis of 15 phase II/III randomized trials.The use of tranexamic acid in microsurgery-is it safe?
P2860

The risk for anemia with targeted therapies for solid tumors

Item
http://www.wikidata.org/entity/Q35989994
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The risk for anemia with targeted therapies for solid tumors
@ast
The risk for anemia with targeted therapies for solid tumors
@en
type
label
The risk for anemia with targeted therapies for solid tumors
@ast
The risk for anemia with targeted therapies for solid tumors
@en
prefLabel
The risk for anemia with targeted therapies for solid tumors
@ast
The risk for anemia with targeted therapies for solid tumors
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
The risk for anemia with targeted therapies for solid tumors
@en
P2093
P2860
P304
P31
P356
10.1634/THEONCOLOGIST.2012-0024
P433
P478
P577
P5875
P698
P932